Page 30 - Webcast Information News Today

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

/PRNewswire/ -- GSE Systems, Inc. ("GSE Solutions", "GSE", or "the Company") (Nasdaq: GVP), a leader in advanced engineering and workforce solutions that...

Announces Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call Introduces Initial Fiscal Year 2023 Guidance ... | August 9, 2022

KOSMOS ENERGY ANNOUNCES SECOND QUARTER 2022 RESULTS DALLAS---August 8, 2022-- Kosmos Energy Ltd. announced today its financial and operating results for the... | August 8, 2022

Second Quarter Glaucoma Franchise Net Revenues of $33.3 Million, up 23% over Second Quarter 2021Outlook for Net Cash Used Expected to Be Less Than $20 Million per Quarter, on Average, for the Remainder of 2022  Aerie Expects to be Cash Flow Break Even During 2024DURHAM, N.C.DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharm...

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

/PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a...

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

/PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a...

Company Received Final Positive Reimbursement Decision for VAZKEPA by UK's NICE in England & Wales Market Access Negotiations and Launch Preparations for VAZKEPA Underway Across Multiple European Markets Initiated